News
1d
TipRanks on MSNAurobindo Pharma Secures USFDA Approval for Rivaroxaban TabletsAurobindo Pharma Ltd ( ($IN:AUROPHARMA) ) has issued an announcement. Aurobindo Pharma Limited has received final approval from the USFDA to ...
Aurobindo Pharma and Gland Pharma have fallen 9 per cent each in the past one week and 22-23 per cent in 2025 so far.
Max, formerly known as HBO Max, officially has a new logo on Sunday night, March 30. The new logo for Warner Bros. Discovery's steaming platform was unveiled on Sunday evening. The new logo gives ...
There’s noticeable anxiety among investors in the pharma and auto sectors ahead of the April 2 deadline, when US President Donald Trump’s tariffs are set to take effect. This has been reflected in the ...
Speaking on Thursday, Trump suggested there would also be specific tariffs on pharmaceuticals as the US "doesn't make anything" in terms of drugs and medicines. "It's in other countries ...
Telangana: Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (US FDA) for ...
All dollar values are in U.S. dollars unless stated otherwise. Eupraxia Pharmaceuticals logo (CNW Group/Eupraxia Pharmaceuticals Inc.) On October 2, 2024, the Company announced the appointment of ...
ET Intelligence Group: The stock of Aurobindo Pharma has lost 13% in 2025 so far, underperforming the 10% drop in the BSE Healthcare index. The lacklustre performance can be attributed to short-term ...
Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...
Aurobindo Pharma rose 1.82% to Rs 1,157.90 after its subsidiary, Apitoria Pharma, received an establishment inspection report (EIR) from the U.S. Food and Drug Administration for its active ...
Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results